Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
Background Breast cancer is associated with increased risk for cardiovascular disease. suPAR (soluble urokinase plasminogen activator receptor) is an immune‐derived signaling glycoprotein implicated in the pathogenesis of atherosclerosis, as well as cancer, representing a shared risk factor for thes...
Saved in:
| Main Authors: | Adithya K. Yadalam, Chang Liu, Yan V. Sun, Anant Mandawat, Arshed A. Quyyumi, Salim S. Hayek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.039728 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
by: Fabien Huet, et al.
Published: (2021-06-01) -
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation
by: Frederik Dencker Wisborg, et al.
Published: (2025-04-01) -
Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study
by: Eman Nagy, et al.
Published: (2025-07-01) -
An emerging role of inflammatory biomarker (suPAR) for prognostic evaluation of atrial fibrillation
by: Nihar Jena
Published: (2025-06-01) -
Significance of suPAR in glomerular diseases
by: RUAN Dong-dong, et al.
Published: (2020-01-01)